Neal Franklin Fowler Insider Trading
Get free email notifications about insider trading for Neal Franklin Fowler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neal Franklin Fowler. Neal Franklin Fowler is a Director in POZEN INC /NC ($POZN) and an Chief Executive Officer in Liquidia Technologies Inc ($LQDA) and a Director in Aralez Pharmaceuticals Inc. ($ARLZ).
Address: POZEN INC. 1414 RALEIGH ROAD, SUITE 400 CHAPEL HILL 27517 NC
Companies in which Neal Franklin Fowler is an Insider
Liquidia Technologies Inc
Trading Symbol: LIQDAIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Neal Franklin Fowler: Chief Executive Officer
Holdings: 86,627 shares
Latest Transaction: Mar 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Old API Wind-down Ltd.
Trading Symbol: ARLZIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neal Franklin Fowler: Director
Holdings: 73,869 shares
Current Value: $309,511
Latest Transaction: May 12 2017
$ARLZ Market Capitalization: $270.87M
$ARLZ Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
POZEN INC /NC
Trading Symbol: POZNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neal Franklin Fowler: Director
Holdings: 50,730 shares
Latest Transaction: Jul 30 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Neal Franklin Fowler
Sentiment: All, LIQDA, ARLZ, POZN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2020 | LIQDA | Liquidia Technolog ... | Fowler Neal Franklin | Chief Executive Off ... | Option Exercise | A | 3.31 | 121,600 | 402,496 | 121,600 | |
Mar 20 2020 | LIQDA | Liquidia Technolog ... | Fowler Neal Franklin | Chief Executive Off ... | Grant | A | 0.00 | 30,400 | 0 | 86,627 | 56.2 K to 86.6 K (+54.07 %) |
Feb 07 2019 | LQDA | Liquidia Technolog ... | Fowler Neal Franklin | Chief Executive Off ... | Option Exercise | A | 14.20 | 96,500 | 1,370,300 | 96,500 | |
Oct 16 2018 | LQDA | Liquidia Technolog ... | Fowler Neal Franklin | Chief Executive Off ... | Grant | A | 0.00 | 11,238 | 0 | 56,227 | 45 K to 56.2 K (+24.98 %) |
Jul 27 2018 | LQDA | Liquidia Technolog ... | Fowler Neal Franklin | Chief Executive Off ... | Option Exercise | A | 11.00 | 192,008 | 2,112,088 | 192,008 | |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Grant | A | 0.00 | 7,500 | 0 | 73,869 | 66.4 K to 73.9 K (+11.30 %) |